Clinical trial
Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer
NCT00203502
Study timeline
Study start (unknown)2005-09-01Date precision: month
Registry last updated2016-05-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
BevacizumabDRUG · verified · RxNorm: bevacizumab
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
University of Arkansaslead sponsor
Genentech, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00203502 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.